RT Book, Section
A1 Bissonnette, Bruno
A1 Luginbuehl, Igor
A1 Engelhardt, Thomas
SR Print(0)
ID 1164073277
T1 Hypereosinophilic Syndrome (HES)
T2 Syndromes: Rapid Recognition and Perioperative Implications, 2e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9781259861789
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1164073277
RD 2024/04/24
AB HES  is  a  myeloproliferative  disorder  characterized  by  the  simultaneous  existence  of  (1)  eosinophil  count  greater  than  1500/mm3  for  more  than  6  months,  (2)  absence  of  any  known  cause  of  eosinophilia,  and  (3)  with  involvement  of  the  heart,  nervous  system,  and  bone  marrow  (benign  eosinophilia  is  excluded).  Patients  without  symptoms  of  chronic  heart  failure  and  responding  well  to  prednisone  have  a  good  prognosis.  However,  the  mortality  rate  rises  in  patients  with  anemia.